General Overview About the Current Management of Nonalcoholic Fatty Liver Disease

por Ampuero, Javier
Publicado 2022

Stratification of patients in NASH clinical trials: A pitfall for trial success

por Ampuero, Javier, Romero-Gomez, Manuel
Publicado 2020

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do

por Sanchez-Torrijos, Yolanda, Ampuero, Javier, Romero-Gómez, Manuel
Publicado 2017

Wilson's disease: Revisiting an old friend

por Lucena-Valera, Ana, Perez-Palacios, Domingo, Muñoz-Hernandez, Rocio, Romero-Gómez, Manuel, Ampuero, Javier
Publicado 2021

Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies

por Rojas, Ángela, García-Lozano, María Rosario, Gil-Gómez, Antonio, Romero-Gómez, Manuel, Ampuero, Javier
Publicado 2022

Emerging pharmacological treatment options for MAFLD

por Rojas, Ángela, Lara-Romero, Carmen, Muñoz-Hernández, Rocío, Gato, Sheila, Ampuero, Javier, Romero-Gómez, Manuel
Publicado 2022

Impact of COVID-19 on liver disease: From the experimental to the clinic perspective

por Gato, Sheila, Lucena-Valera, Ana, Muñoz-Hernández, Rocío, Sousa, José Manuel, Romero-Gómez, Manuel, Ampuero, Javier
Publicado 2021

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases

por Gallego-Durán, Rocío, Montero-Vallejo, Rocío, Maya-Miles, Douglas, Lucena, Ana, Martin, Franz, Ampuero, Javier, Romero-Gómez, Manuel
Publicado 2021

Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease

por Perdomo, Carolina M., Núñez-Córdoba, Jorge M., Ezponda, Ana, Mendoza, Francisco J., Ampuero, Javier, Bastarrika, Gorka, Frühbeck, Gema, Escalada, Javier
Publicado 2022

Extracellular Vesicles as Biomarkers in Liver Disease

por Muñoz-Hernández, Rocío, Rojas, Ángela, Gato, Sheila, Gallego, Javier, Gil-Gómez, Antonio, Castro, María José, Ampuero, Javier, Romero-Gómez, Manuel
Publicado 2022

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients

por Ventura-Cots, Meritxell, Carmona, Isabel, Moreno, Carolina, Ampuero, Javier, Simón-Talero, Macarena, Sanpedro, Francesc, Les, Iñigo, Romero-Gómez, Manuel, Genescà, Joan
Publicado 2017

Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD

por Ampuero, Javier, Gallego-Durán, Rocío, Maya-Miles, Douglas, Montero, Rocío, Gato, Sheila, Rojas, Ángela, Gil, Antonio, Muñoz, Rocío, Romero-Gómez, Manuel
Publicado 2022

Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver

por López-Bermudo, Lucía, Luque-Sierra, Amparo, Maya-Miles, Douglas, Gallego-Durán, Rocío, Ampuero, Javier, Romero-Gómez, Manuel, Berná, Genoveva, Martín, Franz
Publicado 2022

Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients

por Gil-Gómez, Antonio, Rojas, Ángela, Liu, Chang-Hai, Gallego-Duran, Rocio, Muñoz-Hernandez, Rocio, Fassina, Giorgio, Pontisso, Patrizia, Ampuero, Javier, Romero-Gómez, Manuel
Publicado 2021

Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation

por Rey, Esther, Ampuero, Javier, Molina‐Jiménez, Francisca, Marañón, Patricia, García‐García, Yaiza, Múñoz‐Hernández, Rocío, Romero‐Gómez, Manuel, García‐Monzón, Carmelo, Majano, Pedro, González‐Rodríguez, Águeda
Publicado 2021

Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy

por Ampuero, Javier, Ranchal, Isidora, Nuñez, David, Díaz-Herrero, María del Mar, Maraver, Marta, del Campo, José Antonio, Rojas, Ángela, Camacho, Inés, Figueruela, Blanca, Bautista, Juan D., Romero-Gómez, Manuel
Publicado 2012

Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis

por Ruiz-Margáin, Astrid, Macías-Rodríguez, Ricardo Ulises, Ampuero, Javier, Cubero, Francisco Javier, Chi-Cervera, Luis, Ríos-Torres, Silvia L, Duarte-Rojo, Andrés, Espinosa-Cuevas, Ángeles, Romero-Gómez, Manuel, Torre, Aldo
Publicado 2016

Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy

por del Campo, José A., García-Valdecasas, Marta, Gil-Gómez, Antonio, Rojas, Ángela, Gallego, Paloma, Ampuero, Javier, Gallego-Durán, Rocío, Pastor, Helena, Grande, Lourdes, Padillo, Francisco J., Muntané, Jordi, Romero-Gómez, Manuel
Publicado 2018

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool

por Marañón, Patricia, Fernández-García, Carlos Ernesto, Isaza, Stephania C., Rey, Esther, Gallego-Durán, Rocío, Montero-Vallejo, Rocío, de Cía, Javier Rodríguez, Ampuero, Javier, Romero-Gómez, Manuel, García-Monzón, Carmelo, González-Rodríguez, Águeda
Publicado 2022

The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease

por Olveira, Antonio, Augustin, Salvador, Benlloch, Salvador, Ampuero, Javier, Suárez-Pérez, Jorge Alonso, Armesto, Susana, Vilarrasa, Eva, Belinchón-Romero, Isabel, Herranz, Pedro, Crespo, Javier, Guimerá, Francisco, Gómez-Labrador, Lara, Martín, Víctor, Carrascosa, José Manuel
Publicado 2023